Condition: CKD · Metabolic Acidosis · Sponsor: Renibus Therapeutics, Inc.
The purpose of this study is is to evaluate the efficacy and safety of veverimer in treating adults with moderate-to-severe chronic kidney disease (CKD) and metabolic acidosis.
This description comes directly from the study's public registry record.
Ayla Rasmussen · 443-569-9228 · arasmussen@renibus.com
Always discuss trial participation with your own doctor first.
| Study Site | Chula Vista, California, United States | Recruiting |
| Study Site | Los Angeles, California, United States | Recruiting |
| Study Site | Sacramento, California, United States | Recruiting |
| Study Site | San Diego, California, United States | Recruiting |
| Study Site | Aurora, Colorado, United States | Recruiting |
| Study Site | Edgewater, Florida, United States | Recruiting |
| Study Site | Miami Springs, Florida, United States | Recruiting |
| Study Site | Orlando, Florida, United States | Recruiting |
| Study Site | Augusta, Georgia, United States | Recruiting |
| Study Site | Boise, Idaho, United States | Recruiting |
| Study Site | Chubbuck, Idaho, United States | Recruiting |
| Study Site | Idaho Falls, Idaho, United States | Recruiting |
+ 10 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07355062